General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0KRSBQ
ADC Name
IKS-012
Synonyms
IKS 012; IKS012
   Click to Show/Hide
Organization
Iksuda Therapeutics Ltd.
Drug Status
Investigative
Indication
In total 3 Indication(s)
Lung cancer
Clinical candidate
.
Ovarian cancer
Clinical candidate
.
Triple negative breast cancer
Clinical candidate
.
Antibody Name
Undisclosed
Antigen Name
Folate receptor alpha (FOLR1)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed